期刊文献+

浅析临床药师对抗肿瘤药物的药学监护 被引量:19

The Study of Pharmaceutical Care for Antitumor Drugs Provided by Clinical Pharmacists
暂未订购
导出
摘要 从抗肿瘤药物的不良反应和防治措施、掌握药品说明书内容、监护整个用药过程及对患者的用药教育四个方面探讨临床药师对抗肿瘤药物的药学监护,促进抗肿瘤药物的合理使用。临床药师应关注和掌握抗肿瘤药物常见的不良反应及防治措施,掌握抗肿瘤药品说明书的内容,协助医生选择合理的用药方法,监护整个用药过程,做好药品的正确使用、患者的用药教育和健康教育,提高患者的依从性。临床药师只有通过临床实践,真正树立以病人为中心和团队合作共同为病人服务的理念,才能在实践中发现潜在的或实际存在的临床用药问题并正确预防或解决。 The pharmaceutical care includes four aspects:the adverse reactions of antitumor drugs and its prevention measures, grasp the contents of antitumor drugs instructions, monitoring the whole period of using drugs and the education of medication for patients to promote the reasonable use of antitumor drugs though the discuss on pharmaceutical care for anti-tumor drugs provided by clinical pharmacists. Clinical pharmacist should pay attention to adverse reaction of antitumor drugs and its prevention measures. master the contents of antitumor drugs instructions, so as to assist doctors to choose proper medi-cation,Monitoring the whole period of using drugs, strengthening the guidance on the reasonable use of drugs, as well as the patients' medical education and health education, which will improve the obedience of patients. Clinical pharmaceutical must actively participate in clinical work with the belief that“patient as the center”and team cooperation serves for patients. Only this can discover, solve and prevent the potential and actual existence problems in clinical medication practice.
机构地区 酒钢医院药学部
出处 《肿瘤药学》 CAS 2013年第1期70-74,共5页 Anti-Tumor Pharmacy
关键词 临床药师 抗肿瘤药物 药学监护 Clinical pharmacists Anti-tumor drugs Pharmaceutical care
  • 相关文献

参考文献16

  • 1曾东向,任华益,龚倩,符一岚,曹丽芝,伍奕.肿瘤临床药师的药学服务工作探讨[J].肿瘤药学,2011,1(6):549-553. 被引量:12
  • 2刘群,王海莲.静脉化疗药物配制的影响因素及不良反应防治措施[J].中国药师,2007,10(1):83-84. 被引量:14
  • 3Henry DH,Spivak JL. Clinical use of erythropoietin[J].{H}Current Opinions in Hematology,1995,(02):118-124.
  • 4Hortodagyi GN,Frye D,Buzdar AU. Decreased cardiac toxicity of doxorubicin administered by continuos intravenous infusion in cobination chemotherapy for met-astatic breast carcinoma[J].{H}CANCER,1989,(01):37-45.
  • 5Muggia FM,Louie AC,Sikic BI. Pulmonary toxicity of an-titumor agents[J].{H}Cancer Treatment Reviews,1983,(04):221-243.
  • 6Cersosimo RJ. Cisplatin neurotoxicity[J].{H}Cancer Treatment Reviews,1989,(04):195-211.
  • 7卫生部合理用药专家委员会.MCDEX中国医师药师临床用药指南第1版[M]{H}重庆:重庆出版社,20094.
  • 8侯宁.临床静脉用药调配与配伍速查第1版[M]{H}北京:化学工业出版社,20121.
  • 9Bhargava P,Gammon D,McCormick MJ. Hypersensitivity and idiosyncratic reactions to oxaliplatin[J].{H}CANCER,2004,(01):211-212.
  • 10Gammon D,Bhargava P,McCormick MJ. Hypersensitivity reactions to oxalipatin and the application of a desensitiza-tion protocol[J].Oncol,2004,(05):546-549.

二级参考文献12

共引文献42

同被引文献119

引证文献19

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部